HighPoint Advisor Group LLC Sells 495 Shares of Aflac Incorporated (NYSE:AFL)

HighPoint Advisor Group LLC reduced its position in shares of Aflac Incorporated (NYSE:AFL) by 2.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,984 shares of the financial services provider’s stock after selling 495 shares during the period. HighPoint Advisor Group LLC’s holdings in Aflac were worth $1,853,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AFL. Private Trust Co. NA raised its holdings in shares of Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after buying an additional 99 shares in the last quarter. Phillips Wealth Planners LLC raised its stake in Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after acquiring an additional 100 shares in the last quarter. Raleigh Capital Management Inc. lifted its holdings in shares of Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after acquiring an additional 100 shares during the last quarter. TKG Advisors LLC boosted its stake in shares of Aflac by 0.5% in the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after purchasing an additional 103 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC grew its holdings in shares of Aflac by 1.6% during the 4th quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock valued at $720,000 after purchasing an additional 107 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Aflac Price Performance

AFL stock opened at $111.25 on Tuesday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The company’s fifty day simple moving average is $106.58 and its 200 day simple moving average is $107.68. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The firm has a market cap of $60.72 billion, a price-to-earnings ratio of 11.59, a PEG ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.

Insider Transactions at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on AFL. Morgan Stanley raised their target price on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. JPMorgan Chase & Co. raised their price objective on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Piper Sandler cut their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. Finally, Barclays lowered their price objective on Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, February 7th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Aflac has a consensus rating of “Hold” and a consensus target price of $103.36.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.